Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

338.51 -15.49 (-4.38%)
Delayed Quote Updated: 3:30 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
What Cencora (COR) Said on Its Q4 Earnings Call ↗
Cencora (NYSE:COR) reported higher fiscal fourth-quarter revenue and adjusted earnings as specialty drug sales and its acquisition of OneOncology contributed to growth. The company also introduced a... 
Via MarketBeat
Topics ETFs Earnings
News headline image
Cencora (COR) Q4 2026 Earnings Call Transcript ↗
Specialty biologics now drive over half of U.S. pharmaceutical spending. 
Via The Motley Fool
Topics Earnings Economy
Cencora (NYSE:COR) Reports In-Line Q4 Results and Slightly Conservative FY2027 Guidance ↗
Via Chartmill
News headline image
Cencora’s (NYSE:COR) Q3 CY2026 earnings results: revenue in line with expectations
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q4 2026), with revenue up 5.5% year on year to $... 
Via StockStory
Cencora (NYSE:COR): A Quality Stock With Strong EBIT Growth and Cash Conversion ↗
Via Chartmill
News headline image
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
From Cencora
Via Business Wire
News headline image
Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
From Cencora
Via Business Wire
News headline image
Cencora (COR) to report earnings tomorrow: here is what to expect
Healthcare distributor Cencora (NYSE:COR) will be announcing earnings results this Wednesday before the bell. Here’s what to look for. Cencora met analysts’ ... 
Via StockStory
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX –
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
2 large-cap stocks with impressive fundamentals and 1 we ignore
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
Via StockStory
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
From Cencora
Via Business Wire
News headline image
Cencora (COR): 3 Reasons We Love This Stock
Cencora has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 6% to $341.69 per ... 
Via StockStory
Topics Stocks Supply Chain
News headline image
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Cencora Elects Robert E. Sanchez to Its Board of Directors
From Cencora
Via Business Wire
News headline image
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 ↗
Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services... 
Via MarketBeat
Topics ETFs Earnings
News headline image
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference ↗
Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference... 
Via MarketBeat
News headline image
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.79% on an annualized basis producing an average annual return of 20.35%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
2 S&P 500 Stocks with Exciting Potential and 1 We Question
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
Q2 Earnings Outperformers: Cencora (NYSE:COR) And The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cencora (NYSE:COR) and its pe... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basis producing an average annual return of 19.99%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits. ↗
These healthcare companies can actually benefit from inflation. 
Via The Motley Fool
Topics Bonds Economy Government
News headline image
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
Cardinal Health Earnings: Can Perfection Get Priced In Twice? ↗
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend. 
Via MarketBeat
Topics World Trade
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Cencora (COR) Q3 2026 Earnings Call Transcript ↗
Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds. 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.